Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry
Milena Gianfrancesco, Kimme L Hyrich, Sarah Al-Adely, et al.
Annals of the Rheumatic Diseases (2020) Vol. 79, Iss. 7, pp. 859-866
Open Access | Times Cited: 1128

Showing 1-25 of 1128 citing articles:

Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry
Anja Strangfeld, Martin Schäfer, Milena Gianfrancesco, et al.
Annals of the Rheumatic Diseases (2021) Vol. 80, Iss. 7, pp. 930-942
Open Access | Times Cited: 623
Innate immunity: the first line of defense against SARS-CoV-2
Michael Diamond, Thirumala‐Devi Kanneganti
Nature Immunology (2022) Vol. 23, Iss. 2, pp. 165-176
Open Access | Times Cited: 494
Disease‐Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis
Maria Pia Sormani, Nicola De Rossi, Irene Schiavetti, et al.
Annals of Neurology (2021) Vol. 89, Iss. 4, pp. 780-789
Open Access | Times Cited: 432
Aging, Immunity, and COVID-19: How Age Influences the Host Immune Response to Coronavirus Infections?
Varnica Bajaj, Nirupa Gadi, Allison P. Spihlman, et al.
Frontiers in Physiology (2021) Vol. 11
Open Access | Times Cited: 431
American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV‐2 and Hyperinflammation in Pediatric COVID‐19: Version 1
Lauren A. Henderson, Scott W. Canna, Kevin G. Friedman, et al.
Arthritis & Rheumatology (2020) Vol. 72, Iss. 11, pp. 1791-1805
Open Access | Times Cited: 409
American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV‐2 and Hyperinflammation in Pediatric COVID‐19: Version 2
Lauren A. Henderson, Scott W. Canna, Kevin G. Friedman, et al.
Arthritis & Rheumatology (2020) Vol. 73, Iss. 4
Open Access | Times Cited: 399
Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis
Shintaro Akiyama, Shadi Hamdeh, Dejan Micić, et al.
Annals of the Rheumatic Diseases (2020) Vol. 80, Iss. 3, pp. 384-391
Open Access | Times Cited: 366
Risk Factors for Hospitalization, Mechanical Ventilation, or Death Among 10 131 US Veterans With SARS-CoV-2 Infection
George N. Ioannou, Emily R. Locke, Pamela Green, et al.
JAMA Network Open (2020) Vol. 3, Iss. 9, pp. e2022310-e2022310
Open Access | Times Cited: 364
The association of smoking status with SARS‐CoV‐2 infection, hospitalization and mortality from COVID‐19: a living rapid evidence review with Bayesian meta‐analyses (version 7)
David Simons, Lion Shahab, Jamie Brown, et al.
Addiction (2020) Vol. 116, Iss. 6, pp. 1319-1368
Open Access | Times Cited: 361
Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort
Ulf Geisen, Dennis K Berner, Florian Tran, et al.
Annals of the Rheumatic Diseases (2021) Vol. 80, Iss. 10, pp. 1306-1311
Open Access | Times Cited: 344
Outcomes and Risk Factors Associated With SARS-CoV-2 Infection in a North American Registry of Patients With Multiple Sclerosis
Amber Salter, Robert J. Fox, Scott D. Newsome, et al.
JAMA Neurology (2021) Vol. 78, Iss. 6, pp. 699-699
Open Access | Times Cited: 264
The ‘cytokine storm’: molecular mechanisms and therapeutic prospects
Rajendra Karki, Thirumala‐Devi Kanneganti
Trends in Immunology (2021) Vol. 42, Iss. 8, pp. 681-705
Open Access | Times Cited: 254
Cytokine Storm in COVID-19: Immunopathogenesis and Therapy
Christian Zanza, Tatsiana Romenskaya, A Manetti, et al.
Medicina (2022) Vol. 58, Iss. 2, pp. 144-144
Open Access | Times Cited: 240
American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV‐2 and Hyperinflammation in Pediatric COVID‐19: Version 3
Lauren A. Henderson, Scott W. Canna, Kevin G. Friedman, et al.
Arthritis & Rheumatology (2022) Vol. 74, Iss. 4
Open Access | Times Cited: 238
Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow’s triad
Sakir Ahmed, Olena Zimba, Armen Yuri Gasparyan
Clinical Rheumatology (2020) Vol. 39, Iss. 9, pp. 2529-2543
Open Access | Times Cited: 236
Pathogenesis and treatment of cytokine storm in COVID-19
Mehmet Soy, Gökhan Keser, Pamir Atagündüz
TURKISH JOURNAL OF BIOLOGY (2021) Vol. 45, Iss. SI-1, pp. 372-389
Open Access | Times Cited: 229
Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study
José L. Pablos, María Galindo, Loreto Carmona, et al.
Annals of the Rheumatic Diseases (2020) Vol. 79, Iss. 12, pp. 1544-1549
Open Access | Times Cited: 226
Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry
Jeffrey A. Sparks, Zachary S. Wallace, Andrea M. Seet, et al.
Annals of the Rheumatic Diseases (2021) Vol. 80, Iss. 9, pp. 1137-1146
Open Access | Times Cited: 212
COVID-19 vaccine-readiness for anti-CD20-depleting therapy in autoimmune diseases
David Baker, C A K Roberts, Gareth Pryce, et al.
Clinical & Experimental Immunology (2020) Vol. 202, Iss. 2, pp. 149-161
Open Access | Times Cited: 194
American College of Rheumatology Guidance for COVID‐19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 3
Jeffrey R. Curtis, Sindhu R. Johnson, Donald D. Anthony, et al.
Arthritis & Rheumatology (2021) Vol. 73, Iss. 10
Open Access | Times Cited: 191
Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: a phase 4 trial
Ana Cristina de Medeiros Ribeiro, Nádia Emi Aikawa, Carla Gonçalves Schahin Saad, et al.
Nature Medicine (2021) Vol. 27, Iss. 10, pp. 1744-1751
Open Access | Times Cited: 175
Impact of COVID-19 on the care of patients with liver disease: EASL-ESCMID position paper after 6 months of the pandemic
Tobias Boettler, Thomas Marjot, Philip N. Newsome, et al.
JHEP Reports (2020) Vol. 2, Iss. 5, pp. 100169-100169
Open Access | Times Cited: 170
American College of Rheumatology Guidance for COVID‐19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 1
Jeffrey R. Curtis, Sindhu R. Johnson, Donald D. Anthony, et al.
Arthritis & Rheumatology (2021) Vol. 73, Iss. 7, pp. 1093-1107
Open Access | Times Cited: 169
Rheumatic disease and COVID-19: epidemiology and outcomes
Kimme L Hyrich, Pedro Machado
Nature Reviews Rheumatology (2020) Vol. 17, Iss. 2, pp. 71-72
Open Access | Times Cited: 160
COVID-19 in people with rheumatic diseases: risks, outcomes, treatment considerations
Rebecca Grainger, Alfred H.J. Kim, Richard Conway, et al.
Nature Reviews Rheumatology (2022) Vol. 18, Iss. 4, pp. 191-204
Open Access | Times Cited: 159
Page 1 - Next Page

Scroll to top